bacteri
viral
respiratori
tract
infect
result
million
death
worldwid
current
lead
caus
death
infect
acut
inflamm
essenti
element
host
defens
infect
damag
host
left
uncheck
effect
host
defens
requir
multipl
lipid
mediat
collect
proinflammatori
proresolv
effect
lung
pulmonari
infect
phospholipid
acyl
chain
cholesterol
chemic
enzymat
oxid
well
truncat
modifi
produc
complex
mixtur
bioactiv
lipid
review
recent
evid
phospholipid
cholesterol
deriv
regul
pulmonari
innat
adapt
immun
infect
first
highlight
data
oxid
phospholipid
gener
lung
infect
stimul
pattern
recognit
receptor
tlr
scaveng
receptor
therebi
amplifi
pulmonari
inflammatori
respons
next
discuss
evid
oxid
endogen
pool
cholesterol
pulmonari
infect
produc
oxysterol
also
modifi
function
innat
adapt
immun
cell
last
conclud
data
polyunsatur
fatti
acid
form
phospholipid
acyl
chain
enzymat
process
endogen
proresolv
lipid
mediat
aid
resolut
lung
inflamm
distinct
mechan
unravel
complex
mechan
induct
function
distinct
class
bioactiv
lipid
nativ
modifi
may
hold
promis
develop
new
therapeut
strategi
improv
pulmonari
outcom
respons
infect
j
leukoc
biol
abbrevi
alveolar
macrophag
bal
bronchoalveolar
lavag
cd
cluster
differenti
cdc
cell
divis
control
protein
copd
chronic
obstruct
pulmonari
diseas
ctl
cytotox
cxcl
cxc
motif
ligand
cytochrom
famili
subfamili
polypeptid
continu
next
page
journal
leukocyt
biolog
continu
previou
page
damp
dangerassoci
molecular
pattern
dc
dendrit
cell
dha
docosahexaeno
acid
epsteinbarr
virusinduc
gene
epa
eicosapentaeno
acid
matrix
metalloproteinas
myeloid
differenti
primari
respons
gene
oxpapc
oxid
oxpl
oxid
phospholipid
pamp
pathogenassoci
molecular
pattern
pl
phospholipid
pmn
polymorphonuclear
leukocyt
prr
patternrecognit
receptor
pufa
polyunsatur
fatti
acid
ror
retino
acid
receptorrel
orphan
nuclear
receptor
ro
reactiv
oxygen
speci
sp
surfact
protein
spm
special
proresolv
lipid
mediat
sr
scaveng
receptor
trif
tir
domaincontain
adapterinduc
ifnb
respiratori
infect
bacteri
viral
contribut
million
death
worldwid
annual
current
pneumonia
lead
caus
death
infect
therapeut
avail
treat
respiratori
infect
limit
scope
multipl
advers
side
effect
low
efficaci
respiratori
infect
initi
innat
adapt
immun
respons
lung
although
immun
respons
critic
clear
respiratori
pathogen
must
tightli
regul
effect
kill
invad
microorgan
minim
bystand
tissu
injuri
maintain
pulmonari
function
present
review
discuss
evid
class
lipid
mediatorsoxpl
oxysterolsar
gener
infect
mediat
pulmonari
immun
respons
also
explain
pool
exogen
lipid
pufa
incorpor
host
phospholipid
mitig
improv
immunopatholog
associ
bacteri
viral
pneumonia
improv
insight
lipid
mediat
may
ultim
provid
novel
therapeut
target
clinic
manag
pulmonari
infect
respiratori
tract
constantli
expos
outsid
environ
challeng
insult
infecti
inflammatori
first
line
defens
lung
invad
pathogen
resid
cell
lung
structur
ie
respiratori
epitheli
cell
hematopoiet
ie
am
cell
commun
pivot
orchestr
pulmonari
immun
respons
microorgan
epitheli
cell
respiratori
tract
creat
barrier
mediat
product
secretori
mediat
intercellular
junction
protein
secretori
product
upper
lower
airway
includ
mucin
pulmonari
surfact
infect
mucin
product
upregul
part
metaplasia
goblet
cell
serv
prevent
microb
bind
infect
epitheli
cell
pulmonari
surfact
complex
mixtur
lipid
protein
serv
decreas
surfac
tension
alveolu
protect
respiratori
tract
pathogen
hydrophob
spa
spd
collectin
protein
famili
recogn
wide
rang
pamp
includ
found
respiratori
virus
bacteri
fungal
pathogen
associ
toxin
sp
bind
pathogen
promot
opson
subsequ
kill
pathogen
phagocyt
cell
respiratori
tract
am
addit
provid
protect
infect
mucociliari
clearanc
surfact
respiratori
epitheli
cell
also
express
prr
includ
tlr
sr
nodlik
receptor
retino
acidinduc
gene
receptor
recogn
pamp
damp
prr
respiratori
epitheli
cell
stimul
pamp
damp
cytokin
product
initi
downstream
signal
adapt
trif
turn
activ
key
transcript
factor
nfkb
interferon
regulatori
releas
cytokin
chemokin
recruit
innat
adapt
immun
cell
lung
peripheri
pulmonari
infect
downstream
signal
lead
product
proinflammatori
cytokin
tnfa
act
concert
chemoattract
recruit
pmn
lung
kill
pathogen
trifmedi
pathway
respiratori
epithelium
induc
type
ifn
product
ie
ifna
b
type
ifn
signal
critic
host
defens
reveal
mice
lack
receptor
type
ifn
succumb
infect
influenza
viru
activ
type
ifn
produc
sever
specif
antivir
factor
ifninduc
gtpbind
protein
mx
dynaminlik
gtpase
well
variou
cellular
respons
import
cell
recruit
polar
lung
resid
popul
hematopoiet
cellsin
particular
am
dcsthat
patrol
airspac
detect
pamp
contribut
local
milieu
cytokin
chemokin
upon
recogn
pamp
damp
cell
popul
upregul
costimulatori
molecul
essenti
initi
adapt
immun
respons
stimulusmatur
dc
particular
present
ag
migrat
local
lymph
node
addit
cytokin
chemokin
product
am
dc
recruit
innat
immun
cell
pmn
monocytesmacrophag
nk
cell
facilit
kill
infect
cell
pathogen
addit
innat
immun
cell
serv
import
role
respiratori
infect
mast
cell
nk
cell
innat
lymphoid
cell
howev
review
focu
primarili
immun
cell
type
defin
respons
lipid
mediat
recruit
innat
immun
cell
provid
first
line
defens
pulmonari
infect
pmn
nk
cell
monocyt
particular
infiltr
lung
commenc
pathogen
clearanc
pmn
respond
variou
chemokin
produc
am
epitheli
cell
includ
mip
serv
predomin
function
intracellular
extracellular
kill
microb
pmnmediat
kill
essenti
aspect
host
defens
varieti
pulmonari
infect
includ
caus
aspergillu
fumigatu
bordetella
pertussi
pseudomona
aeruginosa
streptococcu
pneumonia
klebsiella
pneumonia
pmn
express
numer
prr
mediat
microbi
kill
product
ro
secret
azurophil
granul
content
lysozym
via
format
neutrophil
extracellular
trap
nk
cell
innat
lymphocyt
also
contribut
first
line
defens
infect
nk
cell
wide
distribut
lymphoid
nonlymphoid
tissu
howev
respiratori
tract
nk
cell
make
higher
percentag
lymphocyt
tissu
abl
respond
quickli
infect
thu
critic
maintain
pulmonari
homeostasi
function
nk
cell
regul
rang
activ
inhibitori
receptor
genet
defici
result
loss
nk
cell
function
associ
recurr
viral
bacteri
infect
includ
upper
lower
respiratori
tract
macrophag
dc
provid
key
bridg
innat
adapt
immun
macrophag
dc
profession
apc
respons
infect
insult
infiltr
tissu
initi
inflammatori
respons
macrophag
key
player
initi
inflamm
also
orchestr
resolut
macrophag
broadli
categor
subset
classic
activ
macrophag
induc
bacteri
cell
wall
compon
lp
combin
cytokin
ifng
tnfa
altern
activ
macrophag
induc
cytokin
macrophag
character
product
ro
reactiv
nitrogen
intermedi
tnfa
addit
macrophag
drive
respons
role
antitumor
immun
kill
intracellular
foreign
pathogen
macrophag
express
scaveng
mannos
receptor
macrophag
subset
regul
wound
heal
restor
tissu
homeostasi
also
antagon
proinflammatori
macrophag
respons
recent
studi
shown
phenotyp
static
macrophag
acquir
antiinflammatori
featur
woundheal
phenotyp
depend
cytokin
milieu
expos
also
evid
subpopul
macrophag
also
character
differenti
express
surfac
receptor
transcript
factor
express
well
function
differ
innat
immun
respons
initi
lung
adapt
immun
respons
call
perform
definit
pathogen
clearanc
protect
reinfect
main
adapt
immun
cell
type
requir
pulmonari
infect
b
cell
cell
migrat
lung
thought
driven
chemokin
gradient
produc
innat
adapt
immun
cell
cell
program
antibodi
product
b
cell
requir
reduct
pathogen
burden
murin
model
influenza
infect
viral
clearanc
depend
upon
cell
individu
howev
genet
delet
cell
type
complet
abolish
viral
clearanc
thu
cell
subset
work
concert
elimin
pathogen
lung
th
cell
assist
b
cell
mount
antibodi
secret
provid
feedback
dc
via
costimulatori
molecul
elabor
cytokin
well
enhanc
maintain
respons
cytotox
cell
moreov
cell
direct
effector
action
includ
perform
cytotox
function
mediat
macrophag
activ
induc
gene
mucos
tissu
contribut
host
defens
polar
cell
effector
cell
determin
cytokin
milieu
strength
signal
associ
ag
present
ag
effector
thcell
subset
includ
character
ifng
secret
tbox
transcript
factor
express
character
secret
express
character
secret
rorgt
express
tregulatori
treg
character
forkhead
box
express
follicular
helper
character
express
bcell
enhanc
secret
th
subtyp
uniqu
essenti
role
pulmonari
immun
respons
respiratori
infect
inappropri
stimul
also
lead
detriment
effect
host
much
like
th
cell
cell
heterogen
activ
howev
context
pulmonari
infect
ctl
perhap
best
character
ctl
play
vital
role
elimin
influenzainfect
cell
lung
agspecif
cytotox
cytokin
chemokin
product
ctl
recogn
infect
cell
foreign
peptid
context
host
mhc
molecul
ctlmediat
kill
induc
secret
poreform
protein
perforin
cytotox
granul
initi
apoptosi
mechan
effect
control
infect
lung
also
lead
signific
inflamm
releas
damp
increas
tissu
injuri
cell
develop
effector
phenotyp
result
ag
stimul
possess
abil
prolifer
surviv
longterm
mainten
adapt
immun
addit
fraction
cell
retain
memori
phenotyp
import
recal
respons
infect
memori
cell
share
epitop
specif
cell
receptor
sequenc
effector
cell
subset
stem
celllik
characterist
b
cell
key
effector
cell
immun
respons
infect
compos
innat
ie
adapt
ie
subset
role
b
cell
infect
mostli
studi
conjunct
divers
antibodi
product
igg
iga
igm
howev
b
cell
also
import
sourc
cytokin
ag
present
respiratori
infect
infect
respiratori
virus
influenza
b
cell
prime
viral
ag
secondari
lymphoid
organ
prime
b
cell
prolifer
shortand
longliv
plasma
cell
memori
b
cell
either
travel
back
lung
form
induc
bronchusassoci
lymphoid
tissu
stay
lymph
node
provid
sourc
neutral
antibodi
primari
infect
also
sourc
protect
reinfect
primari
sourc
phospholipid
pl
lung
pulmonari
surfact
synthes
releas
alveolar
epitheli
type
ii
cell
discuss
surfact
contain
approxim
pl
fatti
acid
chain
oxid
differ
challeng
lung
addit
pl
major
constitu
cellular
membran
releas
cell
death
injuri
oxid
pl
lung
occur
normal
physiolog
metabol
process
also
set
increas
oxid
stress
infect
inflamm
upon
oxid
pl
oxid
varieti
speci
includ
epoxyisoprostan
peipc
povpc
smaller
chemic
fragment
oxpl
gener
either
enzymat
nonenzymat
reaction
induc
ro
product
air
pollut
cigarett
smoke
uv
radiat
oxpl
thought
serv
damp
insofar
stimul
multipl
innat
immun
receptor
lead
prolong
inflamm
downstream
signal
gener
oxpl
clear
multipl
biolog
mechan
includ
enzymat
inactiv
epoxid
hydrolas
aldehyd
dehydrogenas
format
adduct
uptak
sr
neutral
natur
antibodi
creactiv
protein
complement
factor
h
immun
effect
oxpl
infecti
diseas
inevit
dictat
balanc
among
activ
degrad
scaveng
increas
oxpl
level
well
character
diseas
associ
chronic
inflamm
atherosclerot
cardiovascular
diseas
diabet
shown
oxpl
gener
lung
sever
pulmonari
infect
includ
influenza
avian
influenza
sar
coronaviru
bacillu
anthraci
yersinia
pesti
monkey
pox
unclear
primari
sourc
increas
oxpl
pulmonari
infect
howev
one
could
specul
increas
cellular
apoptosi
increas
ro
phagocyt
cell
chang
surfact
pulmonari
inflamm
major
contributor
pivot
paper
imai
et
al
note
oxpl
level
increas
infect
block
oxpl
decreas
pulmonari
inflamm
associ
infect
found
oxplmedi
inflamm
infect
result
activ
trif
pathway
indic
oxpl
serv
damp
amplifi
innat
immun
respons
infect
fig
oxpl
shown
elicit
multipl
immunemedi
effect
infect
inflamm
damp
oxpl
recogn
multipl
prr
includ
macrophag
receptor
collagen
structur
marco
sra
srbi
platelet
activ
factor
receptor
prostaglandin
receptor
tlr
receptor
express
resid
infiltr
cell
lung
therefor
excess
product
oxpl
alter
multipl
cellular
function
import
pulmonari
immun
respons
respiratori
infect
purpos
review
focu
mechan
oxpl
alter
cytokin
secret
product
ro
phagocyt
cell
phagocytosi
adapt
immun
respons
oxpl
may
stimulatori
inhibitori
effect
prr
depend
context
signal
mice
defici
trif
decreas
oxpapcinduc
lung
inflamm
moreov
block
signal
oxpapc
exposur
lead
decreas
product
addit
bone
marrowderiv
macrophag
decreas
cytokin
product
oxpapc
stimul
howev
oxpl
also
report
dampen
effect
pampinduc
cytokin
product
oxpapc
inhibit
macrophag
product
tnfa
stimul
lp
context
lp
signal
oxpapc
report
inhibit
lp
bind
accessori
protein
myeloid
differenti
factor
context
influenza
infect
oxplinduc
inflamm
mediat
trif
drive
increas
product
am
fig
howev
context
innat
immun
challeng
model
lpsinduc
pneumon
wherein
rat
pretreat
intraven
oxpl
reduct
airspac
pmn
microvascular
injuri
proinflammatori
cytokin
note
differ
pulmonari
respons
note
studi
could
result
differ
time
rout
oxpl
deliveri
technic
featur
model
test
taken
togeth
find
studi
demonstr
oxpl
exert
proand
antiinflammatori
effect
innat
immun
respons
oxpl
also
alter
phagocytosi
ro
product
addit
cytokin
secret
studi
shown
oxpapc
inhibit
pkamedi
bacteri
phagocytosi
periton
macrophag
well
set
bacteri
pneumonia
effect
could
result
oxpl
alter
assembl
rho
rac
well
actin
cytoskeleton
remodel
report
vitro
macrophag
phagocytosi
pathogen
typic
coupl
ro
product
play
central
role
kill
intern
microb
note
oxpapc
shown
impair
ro
product
pmn
intrigu
consid
oxpldepend
defect
phagocytosi
ro
gener
may
lead
increas
suscept
respiratori
infect
recent
find
suggest
oxpl
also
modifi
adapt
immun
least
part
effect
innat
immun
cell
dc
treat
oxpapc
display
reduc
upregul
costimulatori
molecul
mhcii
induc
lp
pamp
poli
c
suggest
probabl
downstream
effect
th
cell
program
oxpapc
treatment
dc
also
result
reduc
product
alter
cell
polar
oxid
ldl
also
shown
inhibit
tlr
induct
proinflammatori
cytokin
neg
dc
thu
skew
cell
away
phenotyp
addit
flip
phosphatidylserin
inner
outer
plasma
membran
leaflet
apoptosi
infect
cell
shown
suppress
adapt
immun
respons
dendrit
cell
function
cell
activ
although
effect
oxpl
document
vitro
model
area
oxplmedi
immun
could
ultim
prove
highli
relev
vivo
efficaci
vaccin
design
combat
pulmonari
pathogen
cholesterol
major
neutral
lipid
pulmonari
surfact
thought
promot
spread
mobil
adsorpt
surfact
film
cholesterol
lung
deriv
uptak
circul
plasma
lipoprotein
render
lung
extracellular
surfact
reservoir
sensit
diet
system
metabol
state
cholesterol
overload
lung
particular
pulmonari
macrophag
avoid
revers
cholesterol
transport
tissu
plasma
tissu
involv
interact
cellular
lipid
efflux
transport
eg
atp
bind
cassett
transport
plasma
lipid
acceptor
eg
hdl
intriguingli
increas
number
lipidladen
macrophag
foam
cell
describ
wide
rang
chronic
inflammatori
lung
diseas
suggest
phagocyt
cholesterol
dysregul
may
common
potenti
causal
event
lung
disord
determin
cell
signal
molecular
target
chemic
enzymat
oxid
cholesterol
serv
pivot
regul
inflamm
host
defens
lungspecif
implic
emerg
role
cholesterol
inflamm
immun
howev
recent
begun
defin
cholesterol
level
macrophag
cell
determin
balanc
biosynthesi
mevalon
acid
pathway
receptormedi
uptak
one
hand
regul
efflux
cholesterol
potenti
host
defens
signal
part
promot
signal
interact
socal
cholesterolenrich
lipid
raft
membran
microdomain
multipl
receptor
includ
tlr
cell
receptor
bcell
receptor
mhcii
assembl
activ
raft
cholesterol
also
critic
viral
life
cycl
host
cell
sever
virus
includ
influenza
respiratori
syncyti
viru
hiv
thought
bud
lipid
raft
microdomain
fig
raft
cholesterol
also
regul
invas
multipl
bacteri
pathogen
host
cell
suggest
intrins
perhap
evolutionari
connect
viru
cholesterol
traffick
hdl
receptor
srbi
serv
host
cell
receptor
hcv
niemannpick
endosom
cholesterol
transport
recent
identifi
cellular
receptor
ebola
viru
recent
report
shown
ifndepend
downregul
mevalon
acid
synthesi
pathway
intrins
featur
antivir
host
defens
respons
fig
viral
infect
induc
downregul
enzym
mevalon
acid
pathway
macrophag
autocrin
type
ifn
loop
metabol
respons
essenti
success
host
defens
report
differ
whether
host
cell
protect
deriv
shutdown
new
cholesterol
synthesi
deplet
cellular
isoprenoid
altern
lipid
product
mevalon
acid
synthesi
pathway
deplet
newli
synthes
cholesterol
endoplasm
reticulum
may
potenti
activ
ifn
induct
antivir
receptor
stimul
ifn
gene
potenti
antivir
feedforward
loop
fig
statin
treatment
wildtyp
mice
genetarget
mevalon
acid
synthesi
pathway
mutant
mice
enhanc
host
defens
viru
vivo
includ
lung
infect
suggest
evolutionari
role
cholesterol
antivir
host
defens
antivir
effector
ifninduc
transmembran
report
inhibit
viral
entri
host
cell
via
disrupt
intracellular
cholesterol
traffick
cholesterol
suscept
oxid
analog
case
doubl
bond
unsatur
acyl
chain
surfact
pl
direct
oxid
carbon
doubl
bond
b
ring
cholesterol
ro
like
common
event
pulmonari
surfact
cholesterol
set
inhal
oxid
ozon
ring
oxid
yield
cytotox
oxysterol
bepoxid
clearanc
regul
sr
hand
sever
enzym
known
add
hydroxyl
group
side
chain
carbon
cholesterol
ie
carbon
yield
side
chain
oxysterol
eg
pleiotrop
bioactiv
sever
oxysterolsynthet
enzym
appear
particular
relev
phagocyt
biolog
lung
exampl
highli
express
am
human
lung
product
cholesteno
acid
thought
play
key
role
cholesterol
homeostasi
human
lung
enzym
produc
cholesterol
also
highli
express
lung
mice
like
high
express
am
wwwimmgenorg
recent
shown
highli
complex
effect
inflamm
host
defens
fig
proinflammatori
action
includ
potenti
activ
bind
promot
proinflammatori
gene
chemoattract
leukocyt
via
wherea
potenti
antiinflammatori
action
includ
suppress
inflammasom
repress
nfkb
via
activ
nuclear
receptor
liver
x
receptor
suppress
b
cell
prolifer
iga
class
switch
recent
landmark
discoveri
recognit
ifnstimul
gene
robustli
induc
tlr
agonist
viru
product
potent
antivir
molecul
suppress
viru
inhibit
host
cell
fusion
postfus
event
reportedli
increas
sputum
patient
copd
also
induc
vivo
plasma
human
system
lp
challeng
complex
effect
host
defens
inflamm
like
highli
relev
human
diseas
clearli
warrant
studi
addit
oxysterol
recent
shown
key
role
immun
oxid
product
effect
cytochrom
famili
subfamili
b
polypeptid
recent
shown
chemoattract
multipl
leukocyt
subtyp
via
ligat
gpcr
epsteinbarr
virusinduc
gene
defici
gradient
spleen
respons
mice
fail
posit
splenic
b
cell
outer
follicl
mount
reduc
plasma
cell
respons
immun
challeng
also
play
key
role
posit
dc
margin
zone
bridg
channel
spleen
facilit
captur
present
antibodi
respons
bloodborn
ag
sever
oxysterol
includ
also
report
agonist
rorgt
hallmark
transcript
factor
differenti
thu
mice
defici
enzym
contribut
synthesi
rorgtact
oxysterol
cell
defici
compar
rorgtknockout
mice
case
direct
role
cholesterol
variou
oxysterol
pulmonari
inflamm
immun
yet
demonstr
high
express
relat
oxysterolsynthet
enzym
lung
suggest
cholesterol
metabol
dynam
flux
respons
environment
challeng
like
highli
relev
lung
diseas
direct
studi
thu
clearli
warrant
sterol
diseas
context
innat
adapt
immun
respons
influenc
oxpl
cholesterol
also
fatti
acid
profil
tissu
respons
pharmacolog
agent
diet
particular
longchain
pufa
emerg
potenti
regul
inflamm
long
chain
pufa
essenti
fatti
acid
obtain
marin
sourc
fatti
acid
also
gener
upon
elong
desatur
short
chain
pufa
albeit
latter
may
effici
process
mani
tissu
major
long
chain
pufa
discuss
respect
immun
epa
dha
import
note
epa
dha
addit
pufa
serv
substrat
select
enzym
gener
special
proresolv
lipid
mediat
spm
spm
includ
protectin
resolvin
lipoxin
maresin
potent
molecul
stereospecif
target
gpcr
orchestr
resolut
phase
inflamm
recent
review
elegantli
highlight
studi
spm
aid
resolut
pulmonari
inflamm
therefor
focus
review
key
studi
demonstr
role
epa
dha
dietari
pharmacolog
agent
influenc
lung
inflamm
pulmonari
outcom
infect
first
review
preclin
clinic
studi
epa
dha
use
elucid
role
lung
homeostasi
discuss
potenti
molecular
mechan
epa
dha
context
infect
inflamm
sever
laboratori
examin
rodent
model
pufa
uptak
lung
tissu
influenc
outcom
associ
infect
instanc
pufa
murin
model
promot
resolut
inflamm
associ
enhanc
bacteri
clearanc
surviv
p
aeruginosa
infect
research
also
measur
lung
permeabl
found
effect
pufa
endpoint
anoth
studi
pufa
reduc
frequenc
pmn
lower
level
male
cystic
fibrosi
transmembran
conduct
regul
cftr
null
mice
respons
p
aeruginosa
infect
studi
also
report
gender
differ
demonstr
infect
femal
cftrnull
mice
improv
mortal
lung
permeabl
level
pneumonia
infect
mice
pufa
improv
inflammatori
marker
lung
homogen
bacteri
load
lung
therefor
studi
suggest
potenti
benefici
role
longchain
pufa
inflamm
associ
infect
potenti
benefici
effect
pufa
pulmonari
immun
limit
infect
model
dha
specif
improv
dustinduc
airway
inflamm
reduc
alveolar
pmn
infiltr
inflammatori
cytokin
chemokin
level
rel
match
control
mous
model
bleomycininduc
pulmonari
inflamm
fibrosi
dha
improv
cellular
inflamm
bal
lower
select
arachidon
acidderiv
mediat
increas
secret
even
suggest
administr
pufa
pregnant
dam
may
benefit
offspr
exampl
matern
dha
supplement
improv
pulmonari
function
newborn
murin
model
perinat
inflamm
although
aforement
studi
demonstr
exogen
pufa
administr
benefici
effect
pleiotrop
mechan
discuss
studi
show
neg
consequ
select
pufa
pulmonari
outcom
instanc
dha
administr
mice
aerosol
ovalbumin
model
asthma
led
increas
level
eosinophil
bal
fluid
accompani
high
airway
resist
effect
specif
dha
given
epa
show
neg
effect
anoth
studi
mice
consum
high
level
fish
oil
enrich
pufa
lower
lung
patholog
score
increas
lung
viral
titer
decreas
surviv
influenza
viru
infect
implic
find
clear
given
recent
studi
shown
spm
synthes
dha
improv
mous
surviv
upon
live
influenza
infect
enhanc
antibodi
product
plasma
cell
similarli
spm
protectin
synthes
dha
inhibit
lung
viral
replic
infect
perhap
optim
amount
tissu
pufa
concentr
necessari
improv
pulmonari
outcom
excess
level
pufa
perhap
even
defici
lead
deleteri
effect
moreov
possibl
excess
oxid
pufa
acyl
chain
pl
render
cellular
damag
contribut
excess
inflamm
efficaci
pufa
clinic
level
investig
random
control
trial
hecker
et
al
show
bal
fluid
individu
inhal
lp
given
pufa
show
decreas
proinflammatori
cytokin
pmn
monocyt
compar
control
anoth
studi
pufa
supplement
improv
fraction
exhal
marker
airway
inflamm
healthi
men
review
observ
studi
pufa
copd
reveal
strong
relationship
improv
preval
sever
outcom
copd
hand
data
suggest
correl
serum
inflammatori
marker
copd
shortchain
pufa
level
clinic
trial
parenter
administr
pufacontain
fish
oil
emuls
acut
lung
injuri
also
larg
neg
mechan
pufa
context
pulmonari
infect
inflamm
clinic
basic
scienc
level
extens
investig
thu
review
known
gener
cellular
molecular
mechan
pufa
potenti
involv
modul
lung
patholog
fig
cellular
level
innat
respons
dc
activ
gener
suppress
pufa
seri
studi
cell
cultur
mous
model
demonstr
epa
dha
diminish
lpsinduc
upregul
surfac
molecul
mhcii
consequ
dc
cytokin
secret
activ
cell
suppress
pufa
macrophag
activ
context
obes
also
shown
suppress
dha
less
known
pmn
respons
recent
studi
suggest
high
level
pufa
promot
pmn
activ
thu
steadyst
frequenc
function
innat
cell
involv
pulmonari
respons
may
influenc
pufa
one
studi
pufa
administr
suppress
pmn
infiltr
lung
tissu
mice
polymicrobi
sepsi
adapt
immun
also
modul
pufa
fig
pufa
boost
bcell
activ
antibodi
product
respons
ex
vivo
vivo
stimul
gener
suppress
activ
direct
effect
cell
indirectli
dampen
ag
present
apc
mhcii
improv
inflammatori
outcom
lung
pufa
intervent
report
accompani
lower
percentag
cell
circul
higher
ratio
circul
model
sepsi
effect
pufa
intervent
cytokin
remain
unclear
may
key
import
relat
lung
inflamm
studi
shown
cytokin
elev
pufa
wherea
other
show
opposit
secret
shown
elev
pufa
differ
mous
strain
anoth
studi
pufa
increas
lower
oxid
stress
measur
level
fisoprostan
mice
stimul
ovalbumin
promot
lung
inflamm
still
other
shown
cytokin
dampen
pufa
ovalbumin
model
improv
lung
inflamm
differ
studi
like
attribut
variabl
sourc
pufa
dose
time
intervent
studi
need
establish
specif
level
pufa
lung
tissu
influenc
cytokin
molecular
level
pufa
target
innat
adapt
immun
multipl
overlap
mechan
fig
key
target
plasma
membran
sever
studi
highlight
incorpor
pufa
membran
pl
lead
immunomodulatori
effect
exemplifi
dha
acyl
chain
plasma
membran
pl
restrict
appropri
geometri
key
molecul
within
immunolog
synaps
mhcii
cell
receptor
cytoskelet
compon
figur
potenti
mechan
longchain
pufa
epa
dha
target
innat
adapt
immun
pulmonari
inflamm
epa
dha
target
receptor
potenti
modif
lipid
raft
architectur
influenc
key
immun
respons
respons
rang
inhibit
apct
cell
synaps
format
suppress
inflammatori
cytokin
initi
antibodi
product
key
role
epa
dha
remain
elusiveparticularli
relationship
gener
special
proresolv
lipid
mediat
depict
simplic
respons
exogen
epa
dha
level
aid
resolut
inflamm
inhibit
downstream
gene
express
prolifer
cell
effect
level
membran
driven
chang
lipid
raft
architectur
also
direct
target
receptor
instanc
dha
suppress
macrophag
activ
target
suppress
downstream
signal
pathway
jnk
nfkb
overal
littl
known
role
biophys
plasma
membran
lipidprotein
distribut
lung
inflamm
downstream
plasma
membran
pufa
target
cellular
signal
pathway
converg
multipl
target
therebi
influenc
gene
express
cell
fate
studi
begun
demonstr
relev
pufaregul
signal
lung
patholog
exampl
dha
dampen
apoptosi
lung
associ
chronic
inflamm
epa
report
improv
lung
inflamm
inhibit
ro
signal
human
bronchial
epitheli
cell
epa
lower
nadph
oxidas
activ
ro
pufa
also
directli
target
express
surfac
molecul
like
driven
effect
level
gene
express
exampl
docosapentaeno
acid
elong
product
epa
decreas
matrix
vegf
express
level
lung
tissu
homogen
experiment
pulmonari
rat
hypertens
effect
driven
decreas
mapk
activ
nfkb
transloc
one
mechan
pufa
receiv
scant
attent
research
pufagen
interact
effect
pufa
like
vari
individu
differ
genet
variat
key
enzym
involv
pufa
biosynthesi
metabol
instanc
genet
variant
fatti
acid
desaturas
cluster
key
enzymat
step
pufa
metabol
may
respons
differ
pufa
level
individu
african
european
descent
therefor
extens
studi
pufagen
interact
need
context
lung
patholog
effect
translat
pufa
clinic
trial
final
mechan
high
relev
gener
spm
pufa
discuss
earlier
spm
potent
molecul
aid
resolut
inflamm
sever
studi
demonstr
impact
spm
pulmonari
inflamm
instanc
resolvin
synthes
dha
lower
lung
inflamm
model
cigarett
smoke
howev
remain
unclear
whether
pharmacolog
intak
epa
dha
respect
lead
increas
level
eand
dseri
spm
vivo
studi
shown
pufa
given
human
lead
increas
level
spm
although
studi
question
assumpt
given
discrep
degre
pufa
affect
inflamm
immun
vivo
spm
gener
vs
spmindepend
mechan
remain
unclear
taken
togeth
link
intak
pufa
spm
requir
attent
especi
context
lung
tissu
lipid
broad
class
molecul
rang
role
regul
lung
inflamm
respons
injuri
pl
homeostasi
cholesterol
homeostasi
pufa
metabol
central
exampl
lipid
dynam
interact
environment
factor
lung
influenc
myriad
respons
innat
adapt
immun
connect
mechan
lipid
class
crosstalk
influenc
target
receptor
downstream
signal
lung
central
import
develop
new
therapeut
pulmonari
diseas
incid
lung
diseas
rise
essenti
understand
mediat
singli
combin
modifi
pulmonari
immun
respons
whether
therapeut
opportun
manipul
level
bioactiv
lipid
lung
respiratori
infect
